1. Introduction {#s1}
===============

Schizophrenia is a debilitating mental illness characterized by complex cognitive, affective, and behavioural symptoms that significantly deteriorate an individual\'s quality of life ([@ref1]). Studies adopting magnetic resonance imaging have shown that the complexity and severity of these various symptoms are mirrored in the extent of focal grey and white matter alterations in the brain ([@ref2]; [@ref3]; [@ref4]). A recent review ([@ref5]) has also drawn attention to the reproducible and widespread deficits in functional ([@ref6]; [@ref7]; [@ref8]; [@ref9]; [@ref10]; [@ref11]; [@ref12]; [@ref13]; [@ref14]; [@ref15]) and structural brain connectivity ([@ref10]; [@ref16]; [@ref17]) that are characteristic of schizophrenia. These connectivity abnormalities support the conceptualization of schizophrenia as a disconnection syndrome ([@ref18]; [@ref19]). Accordingly, a comprehensive characterization of the schizophrenia connectome is an important step to understanding the neural basis of this disorder and to developing more accurate biomarkers for diagnosis and treatment efficacy ([@ref8]; [@ref20]; [@ref21]; [@ref22]; [@ref23]; [@ref24]).

The functioning of the human brain is constrained by its anatomical interconnections ([@ref8]; [@ref23]; [@ref25]; [@ref26]; [@ref27]; [@ref28]; [@ref29]; [@ref30]. The most striking example of this can be found in the healthy brain, where the presence of well-myelinated white matter pathways is known to be an accurate predictor of synchronization in neural activity measured between corresponding regions (i.e., functional connectivity, [@ref27]). The converse is not necessarily true; that is, functional connectivity can be established in the absence of a direct structural pathway ([@ref31]; [@ref32]). For example, the functional interplay between two brain regions may be mediated by a third region. Whether the structure--function connectivity relationship is preserved in schizophrenia and in other psychiatric illnesses remains a largely unresolved matter.

To date, a small number of neuroimaging studies have reported spatial coincidence in aberrant indices of both large-scale functional connectivity and structural connectivity in schizophrenia ([@ref33]; [@ref34]; [@ref35]). For instance, in one study concurrently assessing functional and structural connectivity, [@ref35] demonstrate overlapping anatomical and functional alterations in brain networks encompassing the mediofrontal, temporal, parietal and occipital regions. Recent studies investigating the relation between structural connectivity and functional connectivity in schizophrenia have reported evidence of both weaker and stronger structure--function coupling relative to the healthy brain ([@ref36]; [@ref37]), suggesting that variation in this relationship may be cohort and/or network-specific. However, it remains unclear whether abnormal structure--function relationships are convergent with abnormalities in functional and structural connectivity in their own right; such links may point to dependencies between metrics of connectomic pathophysiology that define this disorder.

Given the paucity of research in this area, we sought to assess the structural underpinnings of altered functional connectivity in schizophrenia by investigating whether the association between functional and structural connectivity was preserved in functional networks affected by the disorder. To this end, connectomic techniques were applied to diffusion and resting-state functional imaging data acquired in a sample of well characterized patients with established schizophrenia and a carefully matched group of healthy controls. The network-based statistic (NBS, [@ref35]) was first used to comprehensively test the entire connectome for functional connections showing evidence of abnormal synchronization in patients with schizophrenia. This whole-brain analysis was followed by a selective assessment of the white matter integrity of the anatomical pathways interconnecting the pairs of regions identified as showing abnormal functional connectivity. Finally, we sought to assess whether the relationship between indices of functional and structural connectivity in the networks of interest was altered in the patient group.

Based on our previous investigations ([@ref35]), we hypothesize that the schizophrenia connectome comprises disrupted white matter pathways that are spatially correspondent with pairs of regions showing abnormal resting-state functional connectivity. We further hypothesize that altered functional and structural network connectivity may be linked to a loss of the normal coherence between these measures observed in the healthy brain. Specifically, we expect that stronger structure--function correlations in patients with schizophrenia compared to controls may be a marker of greater rigidity in functional network dynamics of schizophrenia. Conversely, weaker coupling may indicate a randomization of the normal constraints anatomical interconnections impart on brain function.

2. Materials and methods {#s2}
========================

2.1. Participants {#s2.1}
-----------------

Eighteen adults meeting the diagnostic criteria for schizophrenia (Structured Clinical Interview for DSM-IV Axis-I Disorders, [@ref38]) and 18 healthy controls were recruited from the general community. Controls did not meet lifetime criteria for any Axis-I disorder or have a family history of psychosis. Patients with comorbid Axis-I disorders were also excluded, excepting past major depressive episodes or past substance abuse/dependence. Additional exclusion criteria included neurological conditions, significant head injury, electroconvulsive therapy, systemic steroid use, intellectual disability (IQ \< 80), MRI incompatibility or intolerance (e.g. cardiac pace-maker), acute intoxication, and excessive head motion (\>2 mm) during fMRI data acquisition.

One patient was excluded due to excessive head motion and one control participant due to scanner intolerance. The remaining 17 participants in each cohort were closely matched for age, gender, years of education, handedness, and both current and historical substance use (with the exception of greater tobacco intake in patients, [Table 1](#tbl1){ref-type="table"}). As is generally reported, the schizophrenia cohort had a lower full-scale IQ ([@ref39]).

All patients with schizophrenia were compliant to an atypical neuroleptic pharmacotherapy, based on self- and clinician-report. Five patients were additionally taking an antidepressant or mood-stabilizing medication. There were no known cases of extended untreated psychosis. Symptom severity was assessed using the Positive and Negative Syndrome Scale (PANSS, [@ref40]), the Beck Depression Inventory-II ([@ref41]), and the Beck Anxiety Inventory ([@ref42]) ([Table 1](#tbl1){ref-type="table"}). Based on rating scores, patients could generally be classified as mildly to moderately ill ([@ref43]). Patients also endorsed a lower overall quality of life, as assessed by the abbreviated Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q-18, [@ref44]; [@ref45]).

This study was approved and undertaken in accordance with regulations established by the Mental Health Research and Ethics Committee of Melbourne Health; all participants provided written informed consent prior to participation.

2.2. Magnetic resonance imaging {#s2.2}
-------------------------------

Data acquisition was conducted using a Siemens Trio 3 T magnetic resonance scanner at the Murdoch Childrens Research Institute (Melbourne, Australia).

### 2.2.1. Resting-state functional MRI {#s2.2.1}

Over a 10-minute period, 250 whole-brain functional MRI volumes (36 contiguous axial slices; 3 mm thickness) were acquired while participants were awake but performing no explicit cognitive task (i.e., standard eyes open resting-state fMRI protocol). Gradient-echo echo-planar-imaging parameters were as follows: time to repetition (TR) = 2400 ms; time to echo (TE) = 30 ms; flip angle = 90°; field of view (FOV) = 210 × 210 mm; in-plane matrix = 64 × 64; and in-plane resolution = 3.3 × 3.3 mm.

### 2.2.2. Diffusion-weighted MRI {#s2.2.2}

Diffusion MRI was used to quantify the diffusion of water molecules along multiple directions to infer white matter tissue architecture. Sixty diffusion-weighted volumes, each quantifying water diffusion in a unique direction, were acquired using a spin-echo echo-planar imaging sequence with the following parameters: b-value = 2000 s/mm; 64 consecutive axial slices, 2.0 mm thickness; in-plane matrix = 128 × 128; in-plane resolution = 2.0 × 2.0 mm; FOV = 256 × 256 mm; TR = 9350 ms; TE = 104 ms; and flip angle = 90°. Five non-diffusion-weighted volumes were also acquired.

2.3. Data analysis {#s2.3}
------------------

### 2.3.1. Preprocessing: resting-state functional MRI {#s2.3.1}

Preprocessing was performed in MATLAB (version 2012a) using the Data Processing Assistant for Resting-State fMRI toolbox (version 2.2, [@ref46]). The first 4 volumes (10 s) of the acquisition were discarded to allow stabilization of scanner magnetization and subject orientation. The 36 slices within each whole-brain volume were temporally aligned prior to spatial rigid-body coregistration of the 250 volumes. The realigned data were then normalized to Montreal Neurological Institute (MNI) standardized space by first estimating a 12-parameter affine transformation mapping the data volumes to a standard template image. Nonlinear deformations were then estimated to minimize the residual squared difference between the data and the template. The warped data were interpolated to a spatial resolution of 3 mm isotropic, spatially smoothed using a Gaussian kernel having a full-width at half-maximum (FWHM) of 6 mm, and bandpass filtered to isolate relevant low-frequency signal variance in each voxel (0.01--0.08 Hz). The following nuisance parameters were then regressed out of the data at each brain voxel: six standard head motion parameters (3 planes of translation, 3 axes of rotation), frame displacement greater than 0.5 mm (including the preceding and the two subsequent volumes; note that deleting (i.e., scrubbing,[@ref47]) the affected frames yielded very similar results), global signal ([@ref48]; [@ref49]), and signals from the white matter and cerebrospinal fluid. Further exploration indicated that the average number of regressed volumes was small and similar across groups \[*t*~17.81~ = 1.98, *p* \> 0.05; average 0.02% (range 0--0.1%) in controls; 0.09% (0--0.5%) in patients\].

The automated anatomical labelling (AAL, [@ref50]) template was employed to divide the brain into 90 standardized regions-of-interest. The cerebellum was excluded from analysis due to inconsistent sampling across participants during data acquisition. The residuals from the above-described regression were spatially averaged over the voxels comprising each region. This yielded a set of 90 regional time series representing 10 min of intrinsic (resting-state) neural activity for each region. The functional connectivity between each pair of regions was quantified independently with the Pearson correlation coefficient, resulting in a symmetric 90 by 90 connectivity matrix for each participant.

### 2.3.2. Preprocessing: diffusion weighted MRI {#s2.3.2}

Preprocessing was performed using FDT (v2.0), the diffusion toolkit in FSL (FMRIB\'s Software Library; [*http://www.fmrib.ox.ac.uk/fsl*](http://www.fmrib.ox.ac.uk/fsl){#inter-ref001}). Additional preprocessing steps recommended in the recent literature were also performed, as described below ([@ref51]). Diffusion-weighted volumes were manually inspected for large artefacts and then corrected for stretches, shears, and head motion by an affine registration to the first non-diffusion-weighted volume using the *eddycorrect* algorithm. A fractional anisotropy (FA) volume was estimated using weighted linear least squares fitted to the log-transformed diffusion data. The FA volume was then registered to MNI space using the FSL nonlinear registration tool FNIRT. The nonlinear warp was initialized with an affine registration generated with the FSL linear registration tool FLIRT ([@ref52]). The registration target was the average of 58 FA volumes from healthy adults that were well-aligned to MNI152 space. The inverse of the estimated warp field was then applied to the AAL template, producing binary masks for the 90 cortical and subcortical regions in native diffusion space.

### 2.3.3. Probabilistic tractography {#s2.3.3}

Probabilistic streamline tractography was performed using the FSL algorithm ProbtrackX, build 419 (Euler integration; step length: 0.5 mm; curvature threshold: 80°). Local fibre orientations were first estimated using a validated crossing-fibre model ([@ref53]). To map the connectivity between a pair of regions, tractography was performed with one of the regions serving as the seed mask and the other region serving as the termination mask. A total of 500 streamlines were initiated from random locations within each voxel comprising the seed region. Tractography was then repeated with the seed and termination masks interchanged. The result of this was two volumes (connectivity distributions) in which each voxel stored the total number of streamlines that it was intersected by. These two volumes were averaged voxel-wise and thresholded to yield a binary mask of the volume encapsulated by the putative white matter pathway interconnecting the pair of regions. The thresholding was performed such that any voxel intersected by 10 or more streamlines in the averaged map was set to one, while all other voxels were set to zero. FA values of all voxels comprising this binary mask were averaged to yield a connection-specific measure of white matter integrity. This tractography process and tract-specific averaging of FA was repeated identically for each participant in all pairs of regions encompassing the functional networks eliciting a between-group difference. The FA was adopted as an estimate of structural connectivity because of its established link with neurobiological measures of white matter integrity ([@ref54]; [@ref55]). Furthermore, relative to streamlines counts, FA is more normally distributed and resides on a continuous scale, thus better justifying the use of standard statistical approaches.

### 2.3.4. Statistical analysis: functional connectivity {#s2.3.4}

The network-based statistic ([@ref35]) was used to identify networks comprising pairs of regions for which the extent of functional connectivity significantly differed between the patient and control groups. In brief, a two-sample *t*-statistic was calculated for each pair of regions to test the null hypothesis of equality between the patient and control groups in mean functional connectivity. All possible, (90 × 89) / 2 = 4005, pairs of regions were tested. Among the connections exceeding a test-statistic threshold of 3, a search was performed to identify any connected network components. A threshold of 3 was chosen on the basis that it was found to yield consistent findings across the parcellation atlases considered and approximately corresponds to the nominal uncorrected *p*-value of 0.005 (see [@ref56] for discussion about the choice of threshold). The size of each identified network component was measured by the number of supra-threshold connections it comprised. Permutation testing was then performed to estimate a corrected *p*-value for each network. For each of 10,000 permutations, the size of the largest network was recorded to generate a null distribution for calculation of family-wise error corrected statistical thresholds. A corrected *p*-value for a network identified in the actual data was then estimated by the proportion of permutations for which a network of equal or greater size was identified.

The AAL template is one of the most prevalently used regional parcellations for mapping both the functional and the structural human connectome ([@ref57]. We utilized the AAL to maximize the number of existing studies with which our results could be directly compared without the need to determine a template-to-template mapping between discordant regional definitions. Nevertheless, to evaluate the sensitivity of our findings to the regional definitions associated with the AAL, we replicated the above analyses using an alternative regional parcellation scheme comprising 196 cortical and subcortical regions of approximately equal volume *(*[@ref57])*.*

Results were visualized using the software BrainNet Viewer ([@ref58]).

### 2.3.5. Statistical analysis: structural connectivity and structure--function relationship {#s2.3.5}

Three networks comprising pairs of regions for which the extent of functional connectivity significantly differed between the patient and control groups were identified (see [Results](#s3){ref-type="sec"} section). For each of these disrupted networks, a network-wide measure of white matter integrity was calculated. This first involved estimating an edge-specific FA value for each constituent connection (based on tractography-delineated masks; see [Preprocessing: diffusion weighted data](#s2.3.2){ref-type="sec"}) and then averaging these connection-specific FA values across all connections comprising the disrupted network to yield a single network-wide index quantifying white matter integrity ([Fig. 1](#gr1){ref-type="fig"} for examples of tractography-delineated white matter pathways). For each of the three networks, a two-sample one-tailed *t*-test was used to test for a reduction in network-wide white matter integrity in the patient group. This enabled assessment of the hypothesis of co-localization of functional and structural connectivity deficits in the schizophrenia connectome.

For each disrupted network, we further tested for a linear relationship among participants between their levels of functional and structural connectivity. Functional connectivity estimates were averaged over all connections comprising each disrupted network to yield network-wide functional connectivity averages, comparable to determination of network-wide structural connectivity indices *(above)*. Evidence of a linear relationship in these measures of functional and structural connectivity was then assessed for the patient and control groups separately using the Pearson correlation coefficient. Fisher\'s method ([@ref59]) was used to test for between-group differences in the strength of these linear structure--function relationships in each network of interest.

3. Results {#s3}
==========

3.1. Functional connectivity {#s3.1}
----------------------------

Compared to controls, patients with schizophrenia showed altered functional connectivity in three spatially distinct large-scale brain networks ([Fig. 2](#gr2){ref-type="fig"}). *Reduced* functional connectivity was evident in patients in an anterior functional brain network (*p*~FWE~ = 0.011; Network 1 in [Fig. 2](#gr2){ref-type="fig"}). This network comprised 24 brain regions and 29 connections encompassing frontal, fronto-temporal, and fronto-subcortical interactions ([Supplementary Table 1](#s999){ref-type="sec"}). Although changes in functional connectivity involved both brain hemispheres, this network was weighted towards the right hemisphere ([Fig. 2](#gr2){ref-type="fig"}). On average, the valence of this network was positive in controls (*r*~mean~ = 0.11; *t*~16~ = 6.1; *p* \< 0.001) and negative in patients (*r*~mean~ = -0.09; *t*~16~ = -6.6; *p* \< 0.001).

Patients with schizophrenia also showed *reduced* functional connectivity in a posteriorly localized network (*p*~FWE~ = 0.017; Network 2 in [Fig. 2](#gr2){ref-type="fig"}). This network consisted of 24 connections between 18 regions comprising bilateral fronto-occipital, occipito-temporal, occipito-parietal, and parieto-temporal connections ([Fig. 2](#gr2){ref-type="fig"} and [Supplementary Table 1](#s999){ref-type="sec"}). This difference was explained by a lack of significant functional connectivity in patients (*r*~mean~ = -0.03; *t*~16~ = -1.19; *p* = 0.25) while positive connectivity was detected in controls (*r*~mean~ = 0.21; *t*~16~ = 5.84; *p* \< 0.001).

Finally, patients showed *increased* functional connectivity compared to controls in a network primarily encompassing temporo-parietal regions (*p*~FWE~ = 0.007; Network 3 in [Fig. 2](#gr2){ref-type="fig"}). This network encompassed 33 connections between 30 regions and was weighted towards the left hemisphere ([Fig. 2](#gr2){ref-type="fig"} and [Supplementary Table 1](#s999){ref-type="sec"}). Regions encompassing this network were significantly connected in patients (*r*~mean~ = 0.18; *t*~16~ = 11.2; *p* \< 0.001) but not in controls (*r*~mean~ = -0.05; *t*~16~ = -1.78; *p* = 0.09).

These findings were replicated using an alternative, finer-grained parcellation template comprising 192 cortical and subcortical regions ([Supplementary Fig. 1](#s999){ref-type="sec"}).

It is important to remark that the NBS is a method for performing network level inference, and thus the null hypothesis was rejected for each of the three networks as a whole (*p* \< 0.05), but not for any specific connection comprising any network. In other words, between-group differences cannot be declared at the resolution of individual connections in isolation.

3.2. Structural connectivity {#s3.2}
----------------------------

In the first network (Network 1 in [Fig. 2](#gr2){ref-type="fig"}), patients showed a trend-level reduction in white matter integrity (*t*~32~ = 1.63, *p* = 0.057, Cohen\'s d = 0.59; [Fig. 3](#gr3){ref-type="fig"} and [Supplementary Fig. 2](#s999){ref-type="sec"}). On the other hand, comparable between-group white matter integrity was found in Network 2 (*t*~32~ = 0.57, *p* = 0.29, Cohen\'s d = 0.20). Network 3 displayed the same pattern of results as Network 1, namely a trend-level reduction in white matter integrity in the patient group (*t*~32~ = 1.63, *p* = 0.057, Cohen\'s d = 0.53).

3.3. Structure--function relationships {#s3.3}
--------------------------------------

Compared to patients, controls showed a larger correlation between the average functional connectivity and white matter integrity in Network 1 (*Z* = 1.64, *p* = 0.044). As depicted in [Fig. 3](#gr3){ref-type="fig"}, this difference was driven by a positive function--structure relationship in the control group (*r* = 0.43, *p* = 0.032), alongside an absence of correlation in the patient group (*r* = -0.17). These relationships were corroborated using non-parametric Spearman correlations to account for the impact of any outliers in the data (control rho = 0.40; patient rho = -0.13). No between-group differences in function--structure relationships were found for the second (*Z* = 0.06, *p* = 0.48) or the third networks (*Z* = -1.48, *p* = 0.93). Confirmatory analyses excluded that these results were driven by major changes in isolated pairwise connections ([Supplementary Fig. 2](#s999){ref-type="sec"}).

Additional analyses were also performed to account for the potential confounding influence of age, gender, IQ, or substance use (detailed in[Table 1](#tbl1){ref-type="table"}) on between-group differences. Each variable was included as an additional linear regressor in the NBS model assessing functional connectivity alterations and in the linear regression assessing white-matter differences; partial correlations were performed to account for these effects in structure--function relationships. Each confound was assessed in an independent model. Results indicated that the reported connectivity differences were not explained by variance related to any of these factors. Similarly, metrics of sub-clinical anxiety and depression were not predictive of connectivity or connectivity relationships in either cohort. Additionally, measures of function, structure, and function--structure connectivity coupling in the patient group were not significantly correlated with clinical measures, including PANSS scores, disease chronicity, and medication status. Changes in connectivity observed in patients may therefore point to trait-like, enduring disruptions governing brain structure and function, as opposed to state-like metrics of transient abnormality.

4. Discussion {#s4}
=============

This study sought to assess the relationship between abnormalities in functional connectivity in schizophrenia and their structural basis. We first identified alterations in functional connectivity across the whole brain using a cross-sectional experimental design in a well-characterized sample of patients with chronic schizophrenia and matched controls. The integrity of the white matter pathways interconnecting the regions comprising the aberrant functional networks, and the relationship between the observed changes in functional connectivity and white matter integrity, were subsequently assessed. We found that alterations in functional interactions related to schizophrenia can be mapped onto both structural deficits and abnormal structure--function relationships in connections involving the fronto-striatal, fronto-temporal, and fronto-thalamic regions. Aberrant patterns of functional connectivity were also identified between occipito-parietal, occipito-temporal, and parieto-temporal connections, but function--structure relationships were relatively preserved in these networks. Our findings confirm the utility of a multimodal structural--functional approach to schizophrenia connectomics ([@ref36]; [@ref37]).

A number of recent findings from theoretical and empirical studies have shown that structural connectivity constrains patterns of functional connectivity ([@ref27]; [@ref28]; [@ref60]; [@ref61]). In line with this principle of brain organization, we have shown co-localized alterations of functional and structural connectivity in two large-scale brain networks. The first network (Network 1, [Fig. 2](#gr2){ref-type="fig"}) encompassed the frontal, temporal, thalamic, and striatal regions, while the second network (Network 3, [Fig. 2](#gr2){ref-type="fig"}) included regions of the parietal and temporal cortices. Importantly, in the first network, reductions in both functional connectivity and structural connectivity in the patient group occurred in the context of a loss of the normal relationship, relative to the control group, between function and structure ([Fig. 3](#gr3){ref-type="fig"}). Similar deficits in functional and structural connectivity between frontal ([@ref62]), fronto-striatal ([@ref63]; [@ref64], fronto-thalamic ([@ref65]; [@ref66]; [@ref67]), and fronto-temporal ([@ref23]; [@ref68]; [@ref69]) regions have been consistently found in schizophrenia. Specifically, recent research suggests that altered fronto-striatal coupling may be reliable risk phenotypes for psychotic disorders ([@ref63]; [@ref64]; [@ref70]). Our results add to previous findings by suggesting that altered dynamics among regions encompassing Network 1 may result from a reduction of the constraints that white matter connectivity pose on brain function.

In contrast to Network 1, reduced structural integrity in temporo-parietal connections encompassing Network 3 was paralleled by enhanced functional connectivity in schizophrenia. This result is consistent with recent findings suggesting that the impact of minor reductions in structural connectivity can be mitigated by an increase in coupling strength among regions comprising the affected network, without significantly changing the relationship between functional and structural connectivity ([@ref71]). However, temporo-parietal cortices encompassing Network 3 were not functionally integrated in controls. The observed increase in functional integration between temporal and parietal cortices observed in patients may therefore represent a compensatory mechanism induced by more fundamental alterations in the schizophrenia connectome, such as altered integration between regions encompassing Network 1 ([@ref64]).

Patients with schizophrenia were also characterized by a lack of functional integration between temporal, parietal, and occipital cortices (Network 2). In this network, impaired functional connectivity was found in isolation of significant alterations in the structural integrity of the underlying anatomical pathways and changes in function--structure relationships. Thus, decreased functional integration between regions encompassing Network 2 in patients with schizophrenia might be driven by abnormal synaptic plasticity ([@ref31]), as opposed to aberrant anatomical connectivity. Accordingly, our findings suggest the existence of common (Network 1) and distinct (Network 2) pathoaetiologies underlying functional and structural changes in the schizophrenia connectome.

A distinct strength of this study was the recruitment of a cohort of individuals suffering from established schizophrenia in the absence of severe symptomatology, significant drug use history, or comorbid psychiatric conditions. As such, many common confounds to schizophrenia research have been mitigated, increasing confidence that the reported results are related to the phenomenology of the disorder. However, the modest number of patients recruited under such stringent criteria did eschew statistical power. This issue was particularly relevant when relating experimental variables to symptom profiles, given both the small number of samples and the low variability inherent to the clinical measures ([Table 1](#tbl1){ref-type="table"}). Relating altered function--structure connectivity coupling to symptoms of schizophrenia therefore remains a compelling avenue for future investigation. Replication studies will be important in establishing reliability and determining the extent to which these findings relate to different symptom profiles. In particular, larger sample sizes may uncover more subtle alterations in the schizophrenia connectome and allow inference at more conservative statistical thresholds that account for multiple comparisons in structure--function relationships across networks or individual connections. Although we found no relationships between changes in function, structure, and function--structure coupling and antipsychotic medication (chlorpromazine equivalents) or disease chronicity, the potential impact of medication and illness progression on indices of connectivity and their inter-relationships remains an outstanding question. Similar deficits of brain connectivity to those reported herein have, however, been recently reported in larger samples of non-medicated individuals who have a genetic liability for psychosis, as well as in first-episode psychosis ([@ref64]; [@ref72].

In summary, this study highlights the importance of considering not only the separable impact of functional and structural connectivity deficits in relation to the pathophysiology of schizophrenia, but also the implications of the complex nature of their interaction. We report a convergence of reduced functional connectivity, impaired white matter integrity, and a loss of normal function--structure relationships in a network encompassing frontal, striatal, thalamic, and temporal regions. Together, these findings suggest that anatomical connectivity has less of an influence in constraining functional interactions between these regions in schizophrenia.
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![Within each functional network of interest, the average fractional anisotropy (FA) between constituent region-pairs was estimated to provide connection and network-level indices of structural connectivity for each subject. Depicted here are examples of white-matter tractography between 5 region-pairs (relevant to Network 1) in healthy controls and patients with schizophrenia. Visual inspection of tractography outputs was important to exclude problems in fibre tracking. However, our analysis focused on network-level differences and do not allow to declare changes at the level of single connections. Results from confirmatory analyses at the resolution of single connections can be found in [Supplementary Fig. 2](#s999){ref-type="sec"} (a = \#20, b = \#19, c = \#1, d = \#6, e = \#22).](gr1){#gr1}

![Patients with schizophrenia showed decreased functional connectivity in two distinct brain networks (Network 1 and Network 2). Network 1 encompassed pairwise connectivity between frontal, fronto-temporal, and fronto-striatal regions. Network 2 comprised occipito-parietal, occipito-temporal, and parietal--temporal interactions. In a third network (Network 3), encompassing parieto-temporal connections, patients showed increased functional connectivity compared to healthy controls.](gr2){#gr2}

![A significant breakdown in the normal relationship between functional and structural brain connectivity was identified only in Network 1. A significant positive association between functional and structural connectivity was found in healthy participants, while this relationship was lost in patients with schizophrenia. In addition, in Network 1, patients with schizophrenia showed a trend-level reduction in fractional anisotropy (FA) compared to healthy controls (\**p* = 0.057; Cohen\'s d = 0.59).](gr3){#gr3}

###### 

Participant demographics.

                                                                SCZ (n = 17)     CON (n = 17)    Statistic
  ------------------------------------------------------------- ---------------- --------------- --------------------------------------------------------------------
  Demographics, mean (SD)                                                                        
  ????Age, years                                                29.9 (6.7)       27.0 (6.1)      *t*~32~ = 1.31, *p* = 0.20
  ????Gender, M/F                                               16/1             13/4            ?^2^ = 2.11, *p* = 0.15
  ????Education, years                                          13.6 (3.0)       14.6 (1.8)      *t*~32~ = 1.20, *p* = 0.24
  ????Full-scale IQ                                             104 (14.9)       113 (6.1)       ***t*~28~ = 2.43, *p* = 0.022**[a](#ngtbl1.1){ref-type="table-fn"}
  ????Handedness, R/L                                           15/2             17/0            ?^2^ = 2.13, *p* = 0.15
  Illness and symptom measures, mean (SD) or median \[range\]                                    
  ????Age of initial diagnosis, years                           22.5 (4.5)                       
  ????Treatment duration, years                                 7.5 (4.9)                        
  ????PANSS positive                                            13.4 (6.4)                       
  ????PANSS negative                                            12.3 (4.5)                       
  ????PANSS general                                             27.6 (6.2)                       
  ????Beck Depression Inventory                                 16 \[0--41\]     2 \[0--14\]     ***Z* = 3.61, *p* \< 0.001**
  ????Beck Anxiety Inventory                                    7 \[0--36\]      2 \[0--5\]      ***Z* = 2.83, *p* = 0.005**
  ????Quality of life[b](#ngtbl1.2){ref-type="table-fn"}        58.4 (12.2)      70.3 (6.7)      ***t*~32~ = 3.51, *p* = 0.001**
  Substance use measures, median \[range\]                                                       
  ????Alcohol, current drinks/month                             2 \[0--80\]      9 \[0--72\]     *Z* = 1.86, *p* = 0.063
  ????Tobacco, current cigs/day                                 0 \[0--30\]      0 \[0--15\]     ***Z* = 2.46, *p* = 0.049**
  ????Cannabis, lifetime uses                                   77 \[0--3650\]   10 \[0--700\]   *Z* = 1.49, *p* = 0.15
  ????Ecstasy, lifetime uses                                    1 \[0--156\]     0 \[0--30\]     *Z* = 1.50, *p* = 0.18
  ????Amphetamines, lifetime uses                               0 \[0--365\]     0 \[0--4\]      *Z* = 2.00, *p* = 0.092
  ????Cocaine, lifetime uses                                    0 \[0--6\]       0 \[0--15\]     *Z* = 0.75, *p* = 0.63
  ????Hallucinogens, lifetime uses                              0 \[0--8\]       0 \[0--5\]      *Z* = 0.41, *p* = 0.76

Bold entries denote statistical significance; PANSS = Positive and Negative Syndrome Scale.

IQ not measured for 1 control and 3 schizophrenia participants.

Quality of Life Enjoyment and Satisfaction Scale (abbreviated version).

[^1]: These authors contributed equally to the study.
